SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-000124
Filing Date
2022-01-03
Accepted
2022-01-03 07:30:34
Documents
14
Period of Report
2021-12-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm221274d1_8k.htm   iXBRL 8-K 31273
2 EXHIBIT 10.1 tm221274d1_ex10-1.htm EX-10.1 13279
3 EXHIBIT 10.2 tm221274d1_ex10-2.htm EX-10.2 12426
  Complete submission text file 0001104659-22-000124.txt   239663

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA aptx-20211230.xsd EX-101.SCH 3022
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE aptx-20211230_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aptx-20211230_pre.xml EX-101.PRE 22357
8 EXTRACTED XBRL INSTANCE DOCUMENT tm221274d1_8k_htm.xml XML 3704
Mailing Address 909 DAVIS STREET SUITE 600 EVANSTON IL 60201
Business Address 1801 MAPLE AVENUE SUITE 4300 EVANSTON IL 60201 847-871-0377
Aptinyx Inc. (Filer) CIK: 0001674365 (see all company filings)

IRS No.: 474626057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38535 | Film No.: 22500393
SIC: 2834 Pharmaceutical Preparations